Get startedLog in
    Picture of Amgen logo

    AMGN — Amgen News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market

    Picture of Amgen logoAmgen
    24/07/2026 13:13
    BRIEF-Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market
    July 24 (Reuters) - Amgen Inc AMGN.O:
    • AMGEN : SUBMITS DATA TO FDA SEEKING HEARING ON TAVNEOS AVACOPAN IN RESPONSE TO WITHDRAWAL PROPOSAL
    • AMGEN INC: STRONGLY DISAGREES WITH FDA'S PROPOSAL TO WITHDRAW TAVNEOS FROM THE U.S. MARKET
    Source text: [ID:]
    Further company coverage: AMGN.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Amgen

    See all news